Updates in Systemic Therapy for Breast Cancer

Explore the latest advancements in systemic therapy for breast cancer in this comprehensive physician grand rounds presentation by Dr. Sona Patel, an Oncology/Hematology specialist from McFarland Clinic. Delve into crucial topics including breast cancer statistics, screening methods, diagnosis, and workup procedures for abnormal findings. Gain insights into various types of breast cancer and learn about the principles of treating localized breast cancer. Examine the indications for neoadjuvant therapy and discover updates in adjuvant targeted therapies for HER2-positive disease and triple-negative breast cancer. Understand the role of gene expression assays in adjuvant chemotherapy decision-making and explore the optimal duration of adjuvant endocrine therapy. Stay informed about the latest developments in metastatic HER2-positive, HER2-low positive, and triple-negative breast cancer treatments. Conclude with a look at future directions in breast cancer management, equipping yourself with cutting-edge knowledge to enhance patient care and outcomes.

Intro
Objectives
Statistics
Factors relating to Breast Cancer
Screening and diagnosis of breast cancer
Workup for abnormal
Types of Breast Cancer
Principles of Treatment of Localized Breast Cancer
Neoadjuvant Therapy: Indications
Adjuvant Targeted Therapy: Her2 Positive Disease
Adjuvant Targeted Therapy: TNBC
Adjuvant Chemotherapy: Gene Expression Assays
Duration of Adjuvant Endocrine Therapy
Updates in Metastatic Her2 Positive I
Updates in Metastatic Her2 Low Positive
Updates in Metastatic Triple Negative Dis
Conclusions
Future Directions